Arthneeti
All Q2 FY27 results →
BC

Bodal Chemicals Ltd

Q2 FY27Chemicals & Petrochemicals

Bodal Chemicals Q2 Results 2026 (FY27) investor presentation: Revenue & Margins

Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.

Price₹173
Market cap₹2.2K Cr
P/E31.7
Updated3 Nov 2026
Read3 min read

Bodal Chemicals Ltd Q2 FY27 key numbers

Revenue
Q2 FY27 Standalone Revenue: Rs. 8,527 mn, 77.4% growth YoY.

As stated in Bodal Chemicals Ltd's Q2 FY27 investor presentation · published 3 Nov 2026. Reported figures, not investment advice.

Based on Bodal Chemicals Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

The short version

Q2 FY27 Consolidated Revenue: Rs. 8,840 mn, up 77% YoY (from Rs. 5,004 mn in Q2 FY26) (Page 6) EBITDA for Q2 FY27: Rs. 1,276 mn, a 197% year-on-year (YoY) increase (Page 10).

From Bodal Chemicals Ltd's Q2 FY27 earnings-call transcript · updated 3 Nov 2026.

How did Bodal Chemicals' revenue grow in the September 2026 quarter?

  • Q2 FY27 Consolidated Revenue: Rs. 8,840 mn, up 77% YoY (from Rs. 5,004 mn in Q2 FY26) (Page 6)
  • Q2 FY27 Standalone Revenue: Rs. 8,527 mn, 77.4% growth YoY (Page 11)
  • Q2 FY27 Subsidiaries Sales: Mixed performance, e.g., BCTPL up from Rs. 27.8 mn to Rs. 73.7 mn; Sener Boya down 25% (Page 9)
  • Segment Revenue Q2 FY27 (YoY growth):
  • Dye Intermediates: Rs. 3,449 mn, +88% QoQ (Page 5, 8)
  • Basic Chemicals: Rs. 990 mn, +199% QoQ (Page 5, 8)
  • Dyestuffs: Rs. 2,115 mn, +60% QoQ (Page 5, 8)
  • Chlor Alkali: Rs. 908 mn, +8% QoQ (Page 5, 8)
  • Volume data shown per segment on Page 8 (standalone basis), e.g., Dyestuff production increased from 1,322 MT (Q2 FY26) to 2,115 MT (Q2 FY27)

2 more points from Bodal Chemicals Ltd's call on revenue

Create a free account to keep reading this call

What happened to Bodal Chemicals' margins in Q2 FY27?

See what Bodal Chemicals Ltd said on profitability & margins — free account, 30 seconds.

What capex is Bodal Chemicals planning?

  • The presentation mentions a "New greenfield expansion" as part of the company's way forward strategy (Page 28).
  • There is a focus on capacity ramp-up to support growth (Page 28).
  • Capital Work-In-Progress figures are Rs. 517.7 mn (Sep-26) and Rs. 668.6 mn (Mar-26), indicating ongoing investments in assets (Page 12).

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
2Yasho Industries
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Is Bodal Chemicals raising money or cutting debt?

See what Bodal Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.

How big is Bodal Chemicals' order book?

See what Bodal Chemicals Ltd said on order book & pipeline — free account, 30 seconds.

Bodal Chemicals Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Q2 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q2 FY27 numbers from the filing are in the analysis on this page.

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹588 Cr, net profit ₹32 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What Bodal Chemicals's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • Camlin Fine (Q2 FY27)

    Q2 FY27 revenue: Rs 4,915 mn, up 9.15% YoY from Rs 4,503 mn in Q2 FY26 (Page 6, 9) . Key investor presentation takeaways from Camlin Fine Sciences Ltd's Q2 FY27

  • Gujarat Fluoroch (Q2 FY27)

    Consolidated Q2FY27 revenue: ₹1,760 crore, up 45% YoY (Q2FY26: ₹1,210 crore). Key investor presentation takeaways from Gujarat Fluorochemicals Ltd's Q2 FY27 inv

  • Solar Industries (Q2 FY27)

    3,519 crore, up 69% YoY from Rs. Key investor presentation takeaways from Solar Industries India Ltd's Q2 FY27 investor presentation — and how it ranks against

  • Tamil Nadu Petro Products (Q2 FY27)

    For the quarter ended 30-Sep-2026, the standalone revenue from operations was ₹93,437 lakh, up from ₹77,792 lakh in Q2 2025, reflecting a year-on-year…

Compare:vs Solar Industriesvs Pidilite Industriesvs SRF

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Bodal Chemicals Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Bodal Chemicals Ltd Q2 FY27 results?

Q2 FY27 Consolidated Revenue: Rs. 8,840 mn, up 77% YoY (from Rs. 5,004 mn in Q2 FY26) (Page 6) EBITDA for Q2 FY27: Rs. 1,276 mn, a 197% year-on-year (YoY) increase (Page 10).

What is Bodal Chemicals Ltd share price analysis?

Bodal Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 31.7 with a market cap of ₹2,176 Cr. Investors should review the full earnings analysis for detailed insights.

Is Bodal Chemicals Ltd planning capital expenditure?

The presentation mentions a "New greenfield expansion" as part of the company's way forward strategy (Page 28).

Keep Bodal Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.